作者: neoplasm 時(shí)間: 2025-3-21 21:48 作者: 寬宏大量 時(shí)間: 2025-3-22 04:28
Konfiguration der Strategischen Allianz dysfunction, LVOT obstruction, microvascular ischemia, and mitral regurgitation. A small percentage of HCM patients may develop end stage heart failure with impaired left ventricular systolic function. Stroke is another devastating outcome due to atrial fibrillation or thrombus formation in the setting of an apical aneurysm.作者: Perineum 時(shí)間: 2025-3-22 05:51 作者: forager 時(shí)間: 2025-3-22 10:25
https://doi.org/10.1007/978-3-642-47993-9ic cardiomyopathy associated with mid ventricular obstruction, End Stage Heart Failure, Tako-tsubo Cardiomyopathy in patients with Hypertrophic Cardiomyopathy and Tako-tsubo Cardiomyopathy with HCM features.作者: Shuttle 時(shí)間: 2025-3-22 14:07
Hypertrophic Cardiomyopathy: The Past, the Present, and the Future,sarcomeric proteins; more than 1,500 mutations on ten genes have been described..Future challenges include learning more about patients with characteristic mutations but normal phenotypes and the development of drugs that are specifically directed at the molecular abnormalities.作者: 厭食癥 時(shí)間: 2025-3-22 17:46 作者: 別名 時(shí)間: 2025-3-22 22:47 作者: 過于光澤 時(shí)間: 2025-3-23 04:53
,Medical Therapy: From Beta–Blockers to Disopyramide,ic cardiomyopathy associated with mid ventricular obstruction, End Stage Heart Failure, Tako-tsubo Cardiomyopathy in patients with Hypertrophic Cardiomyopathy and Tako-tsubo Cardiomyopathy with HCM features.作者: labile 時(shí)間: 2025-3-23 06:25
Surgical Myectomy and Associated Procedures: Techniques and Outcomes,cific operative techniques have been developed that have shown excellent short and long term outcomes with rare complications. Concomitant cardiac surgery, if required, may be performed safely along with myectomy.作者: 或者發(fā)神韻 時(shí)間: 2025-3-24 08:09
Indications and Outcome of PPM and ICD Placement,apy in high-risk HCM patients, but the early placement of these devices in younger patients may expose them to a higher lifetime risk of complications. Given the unique nature of HCM, specific procedural and programming considerations should be taken into account.作者: Dna262 時(shí)間: 2025-3-24 12:14 作者: Insul島 時(shí)間: 2025-3-24 17:48
,Kulturjournalismus und Popul?rkultur,ated SCD and/or those with sustained ventricular tachycardia, and reasonable for those with massive hypertrophy (>3 cm), unexplained syncope and/or a family history of SCD, and also reasonable for patients with NSVT or abnormal blood pressure response to exercise, but usually when combined with other markers of heightened risk.作者: diabetes 時(shí)間: 2025-3-24 21:20
Weibliche Nutzer von Computerspieleninical significance in patients with HCM is of paramount importance. In this chapter, we will discuss the incidence, diagnosis, medical management, and role of invasive testing and ablation for arrhythmias in HCM patients.作者: 香料 時(shí)間: 2025-3-24 23:39
Approach to Diagnosis: Echocardiography,aphy offers the clinician a comprehensive imaging modality in those with suspected HCM, those previously diagnosed, and those undergoing surveillance or therapeutic intervention. In this chapter, we detail the benefits of echocardiography for the diagnosis, monitoring, and management of those with suspected or known HCM.作者: HEED 時(shí)間: 2025-3-25 05:01
Sudden Cardiac Death Risk Assessment,ated SCD and/or those with sustained ventricular tachycardia, and reasonable for those with massive hypertrophy (>3 cm), unexplained syncope and/or a family history of SCD, and also reasonable for patients with NSVT or abnormal blood pressure response to exercise, but usually when combined with other markers of heightened risk.作者: 天真 時(shí)間: 2025-3-25 09:46
Management of Arrhythmia: Medications, Electrophysiology Studies and Ablation,inical significance in patients with HCM is of paramount importance. In this chapter, we will discuss the incidence, diagnosis, medical management, and role of invasive testing and ablation for arrhythmias in HCM patients.作者: Flounder 時(shí)間: 2025-3-25 11:46 作者: Initial 時(shí)間: 2025-3-25 16:53 作者: 公式 時(shí)間: 2025-3-25 20:43 作者: SCORE 時(shí)間: 2025-3-26 02:00 作者: 保留 時(shí)間: 2025-3-26 04:52 作者: Generosity 時(shí)間: 2025-3-26 10:09 作者: oracle 時(shí)間: 2025-3-26 14:16
http://image.papertrans.cn/h/image/430741.jpg作者: Maximize 時(shí)間: 2025-3-26 18:50
https://doi.org/10.1007/978-1-4471-4956-9Alcohol Septal Ablation; Arrhythmia; Beta–Blockers; Cardiac MRI; Diastolic Heart Failure; Disopyramide; Ec作者: 知識(shí)分子 時(shí)間: 2025-3-26 23:43 作者: 運(yùn)動(dòng)吧 時(shí)間: 2025-3-27 03:41 作者: 清晰 時(shí)間: 2025-3-27 05:57 作者: 刪除 時(shí)間: 2025-3-27 10:43 作者: dyspareunia 時(shí)間: 2025-3-27 17:18 作者: RAFF 時(shí)間: 2025-3-27 19:15
Genetics of HCM and Role of Genetic Testing,of HCM as a complex medical genetic disorder of the sarcomere. To date, over 1,300 mutations in at least 13 disease genes have been identified in patients with HCM. This genetic information has had its greatest impact in the setting of predictive testing in at-risk family members. The genetic testin作者: hysterectomy 時(shí)間: 2025-3-27 22:15 作者: 出生 時(shí)間: 2025-3-28 03:31 作者: 商品 時(shí)間: 2025-3-28 08:16
Pediatric Diagnosis and Management,ompared to this disease in adults. Management and diagnosis in infants and young children in particular are associated with unique considerations. Etiology is an important determinant of survival, particularly in the youngest patients, and pursuit of the specific cause is therefore requisite. Diagno作者: Bouquet 時(shí)間: 2025-3-28 11:27 作者: 得意牛 時(shí)間: 2025-3-28 17:24 作者: nullify 時(shí)間: 2025-3-28 21:44
Lifestyle Modification: Diet, Exercise, Sports and Other Issues,rly understood. Lifestyle adjustments are essential to controlling symptoms, and factors such as diet, fluid intake, caffeine, alcohol and exercise can all have profound effects on patient well-being. However, because HCM physiology can vary widely from patient to patient, physician recommendations 作者: 騙子 時(shí)間: 2025-3-28 22:56 作者: Servile 時(shí)間: 2025-3-29 04:36 作者: Detoxification 時(shí)間: 2025-3-29 07:34
Indications and Outcome of PPM and ICD Placement,t of hypertrophic cardiomyopathy (HCM). Indications for pacing and defibrillators follow the standard guidelines for treatment of conduction disease and arrhythmias in the general population, with distinct additional indications for HCM patients based on the potential to mitigate diastolic dysfuncti作者: 使高興 時(shí)間: 2025-3-29 15:00 作者: Eulogy 時(shí)間: 2025-3-29 16:36 作者: 浪費(fèi)時(shí)間 時(shí)間: 2025-3-29 20:18 作者: olfction 時(shí)間: 2025-3-30 03:42 作者: Genome 時(shí)間: 2025-3-30 07:57 作者: MORPH 時(shí)間: 2025-3-30 09:57
Konfiguration der Strategischen Allianz atients have either resting or provocable left ventricular outflow tract (LVOT) obstruction while others have predominantly non-obstructive forms. A small proportion of patients have apical hypertrophy which can lead to apical aneurysms. This condition affects people of all ages including the pediat作者: 對(duì)待 時(shí)間: 2025-3-30 15:03 作者: TAP 時(shí)間: 2025-3-30 19:56
,Werkst?tten für spanlose Formung,phic cardiomyopathy. The integrated utilization of two-dimensional echocardiography, doppler echocardiography, and stress echocardiography allows for the evaluation of the presence and severity of LV wall thickness, diastolic dysfunction, LVOT obstruction and mitral regurgitation. Thus, echocardiogr作者: ENDOW 時(shí)間: 2025-3-30 23:03 作者: FIS 時(shí)間: 2025-3-31 04:40
E. H. G. Dettmar (o. Professor)of HCM as a complex medical genetic disorder of the sarcomere. To date, over 1,300 mutations in at least 13 disease genes have been identified in patients with HCM. This genetic information has had its greatest impact in the setting of predictive testing in at-risk family members. The genetic testin作者: BILK 時(shí)間: 2025-3-31 05:09 作者: Inveterate 時(shí)間: 2025-3-31 10:54
Einschl?gige Gesetzesbestimmungen these patients: arrhythmogenic causes (bradycardia and tachycardia), left ventricular outflow tract obstruction, and neurocardiogenic causes. An approach to the evaluation of the syncope in terms of etiology, diagnosis, and recommended treatment is presented.作者: 發(fā)炎 時(shí)間: 2025-3-31 14:25
K. Philipp,H. Salzer,E. Reinold,S. Leodolterompared to this disease in adults. Management and diagnosis in infants and young children in particular are associated with unique considerations. Etiology is an important determinant of survival, particularly in the youngest patients, and pursuit of the specific cause is therefore requisite. Diagno作者: Osteons 時(shí)間: 2025-3-31 18:24 作者: 劇毒 時(shí)間: 2025-4-1 01:02 作者: OASIS 時(shí)間: 2025-4-1 05:23
https://doi.org/10.1007/978-3-7091-5386-4rly understood. Lifestyle adjustments are essential to controlling symptoms, and factors such as diet, fluid intake, caffeine, alcohol and exercise can all have profound effects on patient well-being. However, because HCM physiology can vary widely from patient to patient, physician recommendations 作者: insular 時(shí)間: 2025-4-1 07:50
https://doi.org/10.1007/978-3-642-92008-0lthy person. The goals of family screening are to identify relatives with unrecognized HCM and to follow at-risk individuals for risk factors of SCD and disease development..After confirmation of the HCM diagnosis, the patient is informed about the familial character of the disease, the high potenti作者: ACME 時(shí)間: 2025-4-1 10:22 作者: 脆弱帶來 時(shí)間: 2025-4-1 18:20
,Die Geschwülste der Brustdrüse,t of hypertrophic cardiomyopathy (HCM). Indications for pacing and defibrillators follow the standard guidelines for treatment of conduction disease and arrhythmias in the general population, with distinct additional indications for HCM patients based on the potential to mitigate diastolic dysfuncti作者: 良心 時(shí)間: 2025-4-1 22:29
Weibliche Nutzer von Computerspielenr tachycardia (VT) are common. Many of these arrhythmias are asymptomatic, especially if of short duration, but some can precipitate syncope, palpitations, hemodynamic collapse or sudden cardiac death (SCD). Therefore, the evaluation of such arrhythmias, both proactively and reactively, and their cl作者: Soliloquy 時(shí)間: 2025-4-2 00:26
O. Ortmann,F. Lehmann,K. Diedrich of septal reduction therapy (surgical myectomy or alcohol septal ablation), has been demonstrated. However, determining the precise cause of symptoms in the HCM patient, and specifically implicating outflow tract obstructive physiology, can be quite challenging. Accordingly, a detailed and comprehe作者: 護(hù)身符 時(shí)間: 2025-4-2 04:27 作者: 羞辱 時(shí)間: 2025-4-2 08:58
,Weiblichkeit, M?nnlichkeit und Gesundheit,ptoms of heart failure. For those patients with drug-refractory symptoms, alcohol septal ablation is an effective therapy. The outcomes of alcohol septal ablation can approach the gold standard of surgical myectomy when performed in selected patients and in centers that are dedicated to the comprehe作者: 充滿裝飾 時(shí)間: 2025-4-2 12:28
Michael Wagner,Wolfgang Thielerial ischemia, and arrhythmia. Sudden death is not an uncommon complication of HCM, and is often precipitated by exercise. The frequency of sudden death in HCM is up to 1 % per year in adults with 2–4 % per year in children and adolescents.作者: 精確 時(shí)間: 2025-4-2 17:52
,Werkst?tten für spanabhebende Formung,gnostic as well as diagnostic. Magnetic resonance tagging and delayed-enhancement with Gadolinium allow for strain and perfusion analysis, further increasing the utility of CMR to detect regional function and cardiac microvascular ischemia, of which HCM patients are particularly susceptible. Delayed作者: 失眠癥 時(shí)間: 2025-4-2 22:09
